Company profile for Soricimed Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Soricimed Biopharma is developing a novel peptide-based platform targeting TRPV6?a calcium channel overexpressed on solid tumor cancer cells and essential for their growth, metastasis, and survival. These proprietary peptides can function as primary therapeutics or as delivery vectors for other anti-cancer agents. By focusing on TRPV6, Soricimed aims to provide a versatile and targeted approach to cancer treatment with broad t...
Soricimed Biopharma is developing a novel peptide-based platform targeting TRPV6?a calcium channel overexpressed on solid tumor cancer cells and essential for their growth, metastasis, and survival. These proprietary peptides can function as primary therapeutics or as delivery vectors for other anti-cancer agents. By focusing on TRPV6, Soricimed aims to provide a versatile and targeted approach to cancer treatment with broad therapeutic potential.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
18 Botsford St, Suite 201, Moncton, N.B. E1C 4W7
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty